DXZ1/DYZ3 FISH for Sex Mismatched BMT

Clinical Use

Use

DXZ1/DYZ3 FISH for Sex Mismatched BMT is a Fluorescence In Situ Hybridization (FISH) test designed to assess donor bone marrow engraftment in patients who have undergone sex-mismatched bone marrow transplantation (BMT). This test specifically targets centromeric regions of the X and Y chromosomes to evaluate the level of engraftment. The presence of donor cells is crucial for monitoring the success of the transplantation. The results must be interpreted alongside relevant clinical and pathological data to ensure proper assessment and management of the patient's condition. Clinicians should consider patient history and any concurrent treatments that might affect results for accurate conclusions.

Special Instructions

This assay requires that specimens are drawn in sodium heparin tubes and shipped at room temperature in insulated containers. It is vital to ensure that samples arrive at the lab within 48 hours of collection, specifically avoiding any heating or freezing. Appropriate courier services via overnight shipment are recommended to maintain specimen integrity. Clinicians ordering this test should verify that all collection and shipping instructions are strictly followed to avoid any potential issues with sample processing.

Limitations

The FISH assay for DXZ1 and DYZ3 analyzes only the presence and aneuploidy of X and Y chromosomes. It does not detect rearrangements involving these chromosomes or assess other genomic abnormalities that could affect patient outcomes. Additionally, false negatives may occur if the level of engraftment is low or if below the assay's detection limits. Therefore, results should be interpreted cautiously, considering the entire clinical context. Regular follow-up testing may be necessary to monitor ongoing engraftment status.

Test Details